NasdaqGS - Nasdaq Real Time Price • USD
Dynavax Technologies Corporation (DVAX)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 6:36 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 207,542 | 19 |
| Sales | 91,026 | 6 |
| Net Shares Purchased (Sold) | 116,516 | 25 |
| Total Insider Shares Held | 406.21k | -- |
| % Net Shares Purchased (Sold) | 40.10% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BURGESS JUSTIN Officer | Sale at price 12.78 per share. | Direct | 262,322 | Mar 1, 2024 |
| BURGESS JUSTIN Officer | Conversion of Exercise of derivative security at price 9.41 - 11.12 per share. | Direct | 74,232 | Mar 1, 2024 |
| BURGESS JUSTIN Officer | -- | Direct | -- | Feb 16, 2024 |
| NOVACK DAVID F President | Stock Award(Grant) at price 12.48 per share. | Direct | 15,063 | Feb 15, 2024 |
| SPENCER RYAN Chief Executive Officer | Stock Award(Grant) at price 12.48 per share. | Direct | 5,017 | Feb 15, 2024 |
| NOVACK DAVID F President | -- | Direct | -- | Feb 9, 2024 |
| JANSSEN ROBERT Officer | -- | Direct | -- | Feb 9, 2024 |
| SPENCER RYAN Chief Executive Officer | -- | Direct | -- | Feb 9, 2024 |
| MACDONALD KELLY Chief Financial Officer | -- | Direct | -- | Feb 9, 2024 |
| BURGESS JUSTIN Officer | -- | Direct | -- | Feb 9, 2024 |
| NOVACK DAVID F President | -- | Direct | -- | Feb 2, 2024 |
| JANSSEN ROBERT Officer | -- | Direct | -- | Feb 2, 2024 |
| JANSSEN ROBERT Officer | -- | Direct | -- | Feb 2, 2024 |
| SPENCER RYAN Chief Executive Officer | -- | Direct | -- | Feb 2, 2024 |
| BURGESS JUSTIN Officer | -- | Direct | -- | Feb 2, 2024 |
| JANSSEN ROBERT Officer | Sale at price 15.00 per share. | Direct | 22,500 | Jan 4, 2024 |
| JANSSEN ROBERT Officer | Conversion of Exercise of derivative security at price 9.41 per share. | Direct | 14,115 | Jan 4, 2024 |
| NOVACK DAVID F Chief Operating Officer | Sale at price 14.45 per share. | Direct | 130,050 | Jan 2, 2024 |
| NOVACK DAVID F Chief Operating Officer | Conversion of Exercise of derivative security at price 5.42 per share. | Direct | 48,780 | Jan 2, 2024 |
| NOVACK DAVID F President | Sale at price 13.56 per share. | Direct | 271,200 | Dec 1, 2023 |
| NOVACK DAVID F President | Conversion of Exercise of derivative security at price 5.42 per share. | Direct | 108,400 | Dec 1, 2023 |
| NOVACK DAVID F President | Sale at price 15.00 per share. | Direct | 300,000 | Nov 3, 2023 |
| NOVACK DAVID F President | Conversion of Exercise of derivative security at price 5.42 per share. | Direct | 108,400 | Nov 3, 2023 |
| NOVACK DAVID F President | Sale at price 14.12 per share. | Direct | 282,400 | Nov 1, 2023 |
| NOVACK DAVID F President | Conversion of Exercise of derivative security at price 5.42 per share. | Direct | 108,400 | Nov 1, 2023 |
| JANSSEN ROBERT Officer | Sale at price 15.01 per share. | Direct | 26,343 | Oct 10, 2023 |
| JANSSEN ROBERT Officer | Conversion of Exercise of derivative security at price 9.41 per share. | Direct | 16,515 | Oct 10, 2023 |
| NOVACK DAVID F President | Sale at price 14.75 - 15.00 per share. | Direct | 595,000 | Oct 2, 2023 |
| NOVACK DAVID F President | Conversion of Exercise of derivative security at price 5.42 per share. | Direct | 216,800 | Oct 2, 2023 |
| JANSSEN ROBERT Officer | Sale at price 15.03 per share. | Direct | 75,375 | Oct 2, 2023 |
| JANSSEN ROBERT Officer | Conversion of Exercise of derivative security at price 9.41 per share. | Direct | 47,191 | Oct 2, 2023 |
| NOVACK DAVID F President | Sale at price 14.48 per share. | Direct | 289,600 | Sep 1, 2023 |
| NOVACK DAVID F President | Conversion of Exercise of derivative security at price 5.42 per share. | Direct | 108,400 | Sep 1, 2023 |
| JANSSEN ROBERT Officer | Sale at price 15.02 per share. | Direct | 9,012 | Aug 24, 2023 |
| JANSSEN ROBERT Officer | Conversion of Exercise of derivative security at price 9.41 per share. | Direct | 5,646 | Aug 24, 2023 |
| JANSSEN ROBERT Officer | Sale at price 15.01 per share. | Direct | 523,204 | Aug 23, 2023 |
| JANSSEN ROBERT Officer | Conversion of Exercise of derivative security at price 9.41 per share. | Direct | 328,004 | Aug 23, 2023 |
| NOVACK DAVID F President | Sale at price 14.73 - 15.01 per share. | Direct | 594,900 | Aug 8, 2023 |
| NOVACK DAVID F President | Conversion of Exercise of derivative security at price 3.81 - 5.42 per share. | Direct | 176,550 | Aug 8, 2023 |
| JANSSEN ROBERT Officer | Sale at price 15.05 per share. | Direct | 39,130 | Aug 8, 2023 |
| JANSSEN ROBERT Officer | Conversion of Exercise of derivative security at price 9.41 per share. | Direct | 24,466 | Aug 8, 2023 |
| HACK ANDREW A. F. Director | Sale at price 14.39 per share. | Indirect | 21,585,000 | Aug 8, 2023 |
| BURGESS JUSTIN Officer | Sale at price 14.54 per share. | Direct | 117,247 | Aug 7, 2023 |
| BURGESS JUSTIN Officer | Conversion of Exercise of derivative security at price 5.42 - 9.41 per share. | Direct | 65,767 | Aug 7, 2023 |
| HACK ANDREW A. F. Director | Sale at price 12.68 per share. | Indirect | 6,340,000 | Jun 14, 2023 |
| KISNER DANIEL L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 26, 2023 |
| PHILLIPS PEGGY V Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 26, 2023 |
| CANO FRANCIS R. PH.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 26, 2023 |
| MYERS SCOTT DUNSETH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 26, 2023 |
| EASTLAND JULIA MARIE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 26, 2023 |
Related Tickers
EOLS Evolus, Inc.
11.43
-0.26%
DCPH Deciphera Pharmaceuticals, Inc.
14.65
+3.31%
ESPR Esperion Therapeutics, Inc.
1.9000
-4.52%
AVDL Avadel Pharmaceuticals plc
17.81
-0.06%
ELAN Elanco Animal Health Incorporated
13.26
+1.69%
AQST Aquestive Therapeutics, Inc.
4.0700
+3.56%
NBIX Neurocrine Biosciences, Inc.
135.99
-1.28%
VTRS Viatris Inc.
11.57
+0.87%
LNTH Lantheus Holdings, Inc.
65.56
+0.55%
IRWD Ironwood Pharmaceuticals, Inc.
7.82
-3.22%